Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

por Irina Isakova-Sivak, Jørgen de Jonge, Tatiana Smolonogina, Andrey Rekstin, Geert van Amerongen, Harry van Dijken, Justin Mouthaan, Paul Roholl, Victoria Kuznetsova, Elena Doroshenko, Vadim Tsvetnitsky, Larisa Rudenko
Publicado 2014